Interestingly, a recent proteomics study profiling kinase expression in drug-refractory head and neck squamous cell carcinoma identified a number of the same kinases (Lyn, MEK, NEK9) as we did in MYL-R cells, suggesting that these may represent a drug resistance kinome profile [74]. Here, MAP2K7 is linked to head and neck squamous cell carcinoma.